2012
DOI: 10.1038/bjc.2011.535
|View full text |Cite
|
Sign up to set email alerts
|

Personalised cancer follow-up: risk stratification, needs assessment or both?

Abstract: First paragraph: There are approximately 2 million people now living with or beyond cancer in the UK (Maddams et al, 2009) and this number is increasing. Cancer survivors can experience physical, psychological and social consequences as a result of the disease and the treatments received (Jefford et al, 2008; Foster et al, 2009). The effects may be immediate, some of which will resolve and others may persist and become long-term. Late effects can also occur and the interval between the end of treatment and ons… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
95
0
3

Year Published

2013
2013
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 91 publications
(99 citation statements)
references
References 20 publications
1
95
0
3
Order By: Relevance
“…There were no studies identified in either sample group that looked at needs in the follow-up care phase, meaning that there is no research evidence looking at long term unmet needs in patients with haematological cancer; with the growing importance of cancer survivorship, this gap in the literature needs to be addressed [3]. There are some similarities when studies are grouped according to diagnosis and time-point, however, no single group contains more than six studies.…”
Section: Limitationsmentioning
confidence: 98%
See 2 more Smart Citations
“…There were no studies identified in either sample group that looked at needs in the follow-up care phase, meaning that there is no research evidence looking at long term unmet needs in patients with haematological cancer; with the growing importance of cancer survivorship, this gap in the literature needs to be addressed [3]. There are some similarities when studies are grouped according to diagnosis and time-point, however, no single group contains more than six studies.…”
Section: Limitationsmentioning
confidence: 98%
“…For the purposes of this review, an unmet psychosocial need is defined as the desire or requirement for help or support that, where not provided, may negatively impact upon a person's emotional and psychological wellbeing [3,4]. Included papers were required to state that they were measuring need, rather than simply patient concern, as concern does not necessarily equate to a desire for assistance to meet that need.…”
Section: Methodology Eligibility Criteriamentioning
confidence: 99%
See 1 more Smart Citation
“…The Survivorship Sub-group of the National Cancer Research Institute Primary Care Clinical Studies Group recently proposed a framework for risk stratification [25]. They offer a definition of risk stratification as 'the process of quantifying the probability of a harmful effect to individuals resulting from a range of internal and external factors (e.g., demographic characteristics, genetic make-up, medical treatments) and propose that only those long-term and late effects which meet a pre-determined criteria qualify for risk stratification.…”
Section: Discussionmentioning
confidence: 99%
“…1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 The factors which influence poor quality of life (QoL) outcomes in people with HNC become increasingly important as healthcare systems consider how best to utilise finite resources in the follow-up care of a growing number of survivors. The concept of risk stratification has attracted much attention in the context of survivorship care, as it provides a means of quantifying the probability of adverse outcomes in a patient group, and suggests which patients are likely to be at particular risk of poor outcomes, therefore enabling health care professionals to intervene appropriately [13]. Some predictors of poor QoL have been identified including feeding tubes [14] pre-treatment QoL, comorbidity and stage [15].…”
mentioning
confidence: 99%